Clinical Trial Update: Identifying Factors Underlying the Discontinuation of Triptans

View source ↗

Summary

A completed Mayo Clinic trial investigates factors associated with discontinuation of triptans in migraine patients, aiming to understand adherence barriers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Triptans (triptans)

Snippet

Sponsor: Mayo Clinic | Conditions: Migraine, Medication Adherence | Status: COMPLETED